Imtiaz A Malik

Summary

Affiliation: Loma Linda University
Country: USA

Publications

  1. ncbi Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder
    Imtiaz A Malik
    National Cancer Institute, Karachi and Jinnah Hospital, Lahore, Pakistan
    Am J Clin Oncol 26:124-6. 2003
  2. ncbi Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder
    Imtiaz A Malik
    National Cancer Institute, Karachi, Pakistan
    Am J Clin Oncol 26:174-7. 2003
  3. ncbi Clinicopathological features and management of gallbladder cancer in Pakistan: a prospective study of 233 cases
    Imtiaz A Malik
    National Cancer Institute, Karachi, Pakistan
    J Gastroenterol Hepatol 18:950-3. 2003
  4. ncbi Use of CAM results in delay in seeking medical advice for breast cancer
    Imtiaz A Malik
    National Cancer Institute, Karachi, Pakistan
    Eur J Epidemiol 18:817-22. 2003
  5. ncbi Gallbladder cancer: current status
    Imtiaz A Malik
    Loma Linda University Medical Center, Division of Hematology Oncology, 11234 Anderson St, Suite 1531, Loma Linda, CA 92354, USA
    Expert Opin Pharmacother 5:1271-7. 2004
  6. ncbi Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
    Alexander Liede
    University of Toronto, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
    Am J Hum Genet 71:595-606. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder
    Imtiaz A Malik
    National Cancer Institute, Karachi and Jinnah Hospital, Lahore, Pakistan
    Am J Clin Oncol 26:124-6. 2003
    ..In conclusion, 5-FU and folinic acid (Mayo Clinic regimen) is ineffective in the management of patients with advanced gallbladder cancer, and further trials with this regimen are not recommended...
  2. ncbi Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder
    Imtiaz A Malik
    National Cancer Institute, Karachi, Pakistan
    Am J Clin Oncol 26:174-7. 2003
    ..If confirmed by others, it may provide an important therapeutic option in managing these patients who otherwise have a dismal prognosis...
  3. ncbi Clinicopathological features and management of gallbladder cancer in Pakistan: a prospective study of 233 cases
    Imtiaz A Malik
    National Cancer Institute, Karachi, Pakistan
    J Gastroenterol Hepatol 18:950-3. 2003
    ..This study was performed to evaluate and compare the clinicopathological features and management of gallbladder cancer in Pakistani patients, with particular emphasis on factors that influence survival...
  4. ncbi Use of CAM results in delay in seeking medical advice for breast cancer
    Imtiaz A Malik
    National Cancer Institute, Karachi, Pakistan
    Eur J Epidemiol 18:817-22. 2003
    ..Breast cancer patients in Pakistan frequently (53%) delay seeking medical advice. Antecedent practice of CAM is widespread and a common underlying reason. The delay results in significant worsening of the disease process...
  5. ncbi Gallbladder cancer: current status
    Imtiaz A Malik
    Loma Linda University Medical Center, Division of Hematology Oncology, 11234 Anderson St, Suite 1531, Loma Linda, CA 92354, USA
    Expert Opin Pharmacother 5:1271-7. 2004
    ..The availability of better drugs and combinations may affect the use of chemotherapy in neoadjuvant and adjuvant settings. Novel targeted therapies require exploration alone or in combination with chemotherapy...
  6. ncbi Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
    Alexander Liede
    University of Toronto, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
    Am J Hum Genet 71:595-606. 2002
    ..7; 95% CI 1.5-4.9; P=.0008) and case subjects with ovarian cancer (OR=2.4; 95% CI 1.4-4.2; P=.002). These results suggest that recessively inherited genes may contribute to breast and ovarian cancer risk in Pakistan...